Skip to content

High-Dose Rate Brachytherapy

RADIATION10 trials

Sponsors

Rutgers, The State University of New Jersey, National Cancer Institute (NCI), Sidney Kimmel Cancer Center at Thomas Jefferson University, Oslo University Hospital, Jonsson Comprehensive Cancer Center

Conditions

Advanced Cervical AdenocarcinomaAdvanced Cervical Adenosquamous CarcinomaAdvanced Cervical Squamous Cell CarcinomaAdvanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell CarcinomaCervical AdenocarcinomaCervical Adenosquamous Carcinoma

Phase 1

Phase 2

Unknown Phase

Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
CompletedNCT02899221
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityRecurrent Prostate Carcinoma
Start: 2017-03-21End: 2025-10-29Updated: 2026-02-20
Experiences With HDR-brachytherapy in Norway
CompletedNCT03162523
Oslo University HospitalProstate Cancer
Start: 2004-01-31End: 2016-10-15Updated: 2017-05-25
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
WithdrawnNCT04399824
Jonsson Comprehensive Cancer CenterProstate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v8, Stage IIB Prostate Cancer AJCC v8 +3
Start: 2020-04-03End: 2020-04-03Updated: 2020-11-06
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
RecruitingNCT04725903
Emory UniversityStage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 +1
Start: 2021-02-01End: 2027-12-31Target: 30Updated: 2026-02-17
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
RecruitingNCT04945642
Jonsson Comprehensive Cancer CenterProstate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC v8 +5
Start: 2021-08-20End: 2027-07-01Target: 52Updated: 2025-07-15
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Not yet recruitingNCT07468903
Jonsson Comprehensive Cancer CenterProstate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Start: 2026-04-04End: 2032-04-04Target: 45Updated: 2026-03-19

Related Papers